NASDAQ
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Open
$40.25
Previous Close
$39.95
Day High
$40.59
Day Low
$39.79
52 Week High
$40.82
52 Week Low
$13.42
No price data available for this timeframe.